Cargando…

DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy

DPP4 (dipeptidyl peptidase 4) is expressed in many cancers, but the relationship between DPP4 and thyroid carcinoma (THCA) is incompletely understood. We aim to explore the expression of DPP4 in THCA and the correlation between DPP4 expression with the prognosis of THCA and antitumor immunity. We sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiaoqian, Le, Yali, Geng, Chenchen, Jiang, Zhen, Zhao, Guanghui, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715318/ https://www.ncbi.nlm.nih.gov/pubmed/36467461 http://dx.doi.org/10.1155/2022/5181386

Ejemplares similares

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

Establishment and validation of a nomogram to predict structural incomplete response in papillary thyroid carcinoma patients: a retrospective study
por: Geng, Chenchen, et al.
Publicado: (2023)

Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy
por: Zhang, Yan-Peng, et al.
Publicado: (2020)

Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma
por: Horie, Kuniko, et al.
Publicado: (2023)

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
por: Gao, Xiaoni, et al.
Publicado: (2023)

Potential Role of Cuproptosis-Related Lncrna in Prognosis and Immunotherapy of Thyroid Carcinoma
por: Cai, Yunying, et al.
Publicado: (2023)

Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma
por: Wu, Min, et al.
Publicado: (2022)

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
por: Rafii, Soumaya, et al.
Publicado: (2023)

Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma
por: Qin, Guohui, et al.
Publicado: (2017)

Transcription profiling in papillary thyroid carcinoma reveals potential diagnostic markers and drug targets
por: Filho, Mateus CB, et al.
Publicado: (2013)

PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma
por: Birnbaum, David Jeremie, et al.
Publicado: (2023)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report
por: Ma, Dong-Xu, et al.
Publicado: (2022)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4
por: Wang, Yufei, et al.
Publicado: (2019)

DPP shapes up wing cells
por: LeBrasseur, Nicole
Publicado: (2005)

DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma
por: Xia, Fada, et al.
Publicado: (2019)

Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
por: Javidroozi, Mazyar, et al.
Publicado: (2012)

Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma
por: Shi, Yunpeng, et al.
Publicado: (2018)

Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin
por: Cheng, Sheng-Yao, et al.
Publicado: (2022)

DPP4 as a Potential Candidate in Cardiovascular Disease
por: Chen, Si-Yu, et al.
Publicado: (2022)

25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2016)

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
por: Vuong, Huy Gia, et al.
Publicado: (2017)

CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma
por: Nishina, Sohji, et al.
Publicado: (2022)

FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma
por: Shen, Ting, et al.
Publicado: (2022)

SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma
por: Al-Kuraya, Khawla S, et al.
Publicado: (2020)

DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma
por: Li, Ming, et al.
Publicado: (2020)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
por: Liu, Jinglong, et al.
Publicado: (2014)

Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
por: Mai, Jialuo, et al.
Publicado: (2022)

ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma
por: Hu, Xinyao, et al.
Publicado: (2023)

The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway
por: Yu, Zhen-xing, et al.
Publicado: (2022)

DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015)

PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma
por: Chen, Yinkui, et al.
Publicado: (2022)

Involvement of DPP9 in gene fusions in serous ovarian carcinoma
por: Smebye, Marianne Lislerud, et al.
Publicado: (2017)

Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
por: Gómez Sáez, José M
Publicado: (2011)

Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017)

PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022)

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
por: Xu, Ke, et al.
Publicado: (2023)

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction
por: Li, Jing-Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dojl14nhf351n28bfli79c1aac